BJH - volume 6, issue 3, september 2015
No authors
(BELG J HEMATOL 2015;6(3):129)
Read moreBJH - volume 6, issue 3, september 2015
No authors
Concentrates of coagulation factors VIII and IX have good haemostatic effects on acute bleeding and during surgical intervention in patients with hemophilia A and B. However, the current agents used in this setting are mostly short-acting, making therapy troublesome for patients. Currently, new clotting factor concentrates are becoming available, or are in advanced clinical studies which will significantly improve the treatment for patients with hemophilia A and B. Various bioengineering concepts have been applied to modified recombinant FVIII, FIX and FVII proteins.1 These different technologies were summarised in an educational presentation during the 2015 annual EHA meeting by Dr. Johannes Oldenburg (University Clinic Bonn, Germany).
(BELG J HEMATOL 2015;6(3):130–1)
Read moreBJH - volume 6, issue 1, march 2015
A. Bosly MD, PhD
Once more, the plenary session of the American Society of Hematology held in the San Francisco Moscone Centre on December 7th, was of the highest level of quality.
(BELG J HEMATOL 2015;6(1):40–2)
Read moreBJH - volume 5, issue 3, september 2014
T. Lodewyck MD
From 30 March – 2 April 2014, the annual meeting of the European Society for Blood and Marrow Transplantation was held in Milan, Italy. At this 40th anniversary meeting, the society celebrated 40 years of physicians meetings, 30 years of nurses meetings and introduced its first donor day. Some of the highlights of this meeting are summarised.
(BELG J HEMATOL 2014;5(3):113–14)
Read moreBJH - volume 5, issue 2, june 2014
V. Labarque MD, PhD
A summary of the BSPHO program hosted by the general annual meeting of the BHS in Ghent on Friday, January 31st, 2014.
(BELG J HEMATOL 2014;5(2):68–71)
Read moreBJH - volume 5, issue 2, june 2014
A. Gothot MD, PhD, A. Kornreich MD
A summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent on Friday, January 31st, 2014.
(BELG J HEMATOL 2014;5(2):72–6)
Read moreBJH - volume 5, issue 1, march 2014
A. Bosly MD, PhD
Many important advances in the knowledge and treatment of lymphoma were presented in New Orleans during the 2013 ASH meeting.
(BELG J HEMATOL 2014;5(1):31–32)
Read more
Top
